在驾驶
发表于 2025-3-25 05:41:20
http://reply.papertrans.cn/83/8285/828469/828469_21.png
ENDOW
发表于 2025-3-25 07:32:02
http://reply.papertrans.cn/83/8285/828469/828469_22.png
庄严
发表于 2025-3-25 12:14:23
Pathophysiology: Metabolic Alterations and Risk Factorss for screening activities to find and target resistant hypertension, as well as measures to improve lifestyle and psychosocial conditions in order to improve compliance with drug medication and improved pharmacological effect of antihypertensive drugs. If this is not enough, other methods such as renal nerve ablation have to be considered.
Infusion
发表于 2025-3-25 15:54:38
http://reply.papertrans.cn/83/8285/828469/828469_24.png
新星
发表于 2025-3-25 21:20:57
http://reply.papertrans.cn/83/8285/828469/828469_25.png
innovation
发表于 2025-3-26 02:26:30
http://reply.papertrans.cn/83/8285/828469/828469_26.png
Blatant
发表于 2025-3-26 07:53:30
False Versus True Resistant Hypertensionments. However, given the acknowledged limitations of office blood pressure in assessing blood pressure control, a first step in the diagnostic approach of the patient with resistant hypertension consists in defining whether resistance to antihypertensive treatment is true or whether the persisting
corpuscle
发表于 2025-3-26 08:55:19
http://reply.papertrans.cn/83/8285/828469/828469_28.png
我不怕牺牲
发表于 2025-3-26 14:28:20
24-hour Ambulatory BP Monitoring and Home BP Measurements in Resistant Hypertensionsion. In fact 24 h ABPM has been considered mandatory at the time to evaluate resistant hypertension from the beginning of clinical use. Furthermore, clinical research has expanded the potential role of out-of-office measurements not only to the initial evaluation of resistant hypertension but also
BUOY
发表于 2025-3-26 18:19:17
Factors Predicting Blood Pressure Response to Treatmentctors influencing the effect of antihypertensive drugs should be highlighted. These factors are related to the patients and to the drugs. Age, smoking, dietary habits, lifestyle, psychological factors, living conditions, therapeutic adherence/persistence, concomitant illnesses, racial, and genetic d